The Tobacco Regulation Act in the USA is a law that requires warning labels for smokeless tobacco products and ensures that “modified risk statements” are supported by scientific evidence. It also requires the disclosure of ingredients in tobacco products and gives the FDA the authority to regulate the manufacture, distribution, and marketing of cigarettes, smoking tobacco, roll-up tobacco, and smokeless tobacco. The responsibilities of the CTP (Center for Tobacco Products) under this law include setting performance standards, reviewing pre-marketing applications for new and modified hazardous tobacco products, requiring new warning labels, and establishing and enforcing advertising and promotion restrictions. The FDA is dedicated to educating the public, especially young people, about the harms of tobacco products, keeping them out of reach of young Americans, and reducing their attractiveness.
The Act also authorizes the Commission to enforce sanctions against advertisements that violate the tobacco-related provisions of the Food, Drug and Cosmetic Act or its rules. It also requires coordination and consultation between the Commission and the Department with respect to warning labels for cigarettes and smokeless tobacco products. In order to reduce tobacco-related deaths and illnesses in the United States, NIH (National Institutes of Health) and FDA (Food and Drug Administration) have formed a partnership to promote tobacco regulatory research. This research will help to create a healthier future for all Americans by providing evidence-based information on the effects of tobacco use.
